NHLBI single-site investigator-initiated clinical trials (R61/R33)
This NHLBI funding opportunity supports investigator-initiated single-site Phase II+ clinical trials using a two-phase, milestone-driven R61 (up to 1 year) → R33 (up to 4 years) mechanism. The R61 funds start-up activities (protocol finalization, manuals/CRFs, IRB/DSMB setup, partnerships, and IND/IDE confirmation if needed), and progression to the R33 full-enrollment phase requires meeting ag…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers